These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 573904)

  • 21. Hypothalamic-pituitary-adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress.
    Zhou Y; Spangler R; Maggos CE; Wang XM; Han JS; Ho A; Kreek MJ
    J Endocrinol; 1999 Nov; 163(2):261-7. PubMed ID: 10556776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of the effects of morphine on adrenal corticosteroids, ascorbic acid and catecholamines in unanaesthetized and anaesthetized cats.
    Borrell J; Llorens I; Borrell S
    Horm Res; 1974; 5(6):351-8. PubMed ID: 4372139
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of clonidine on pituitary-adrenocortical axis in morphine-tolerant rats and after naloxone-induced withdrawal.
    Vargas ML; Gonzalvez ML; Martinez JA; Arias L; Bruger AJ; Milanés MV
    Pharmacology; 1992; 44(3):158-64. PubMed ID: 1579597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma catecholamine concentrations during morphine withdrawal in conscious guinea-pigs.
    Brent PJ; Johnston PA; Chahl LA
    Clin Exp Pharmacol Physiol; 1987 Aug; 14(8):623-31. PubMed ID: 3440321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Piracetam modifies morphine and related drug-induced elevation of serum corticosterone concentration in rats.
    Korányi L; Endröczi E
    Acta Physiol Hung; 1983; 62(1):75-83. PubMed ID: 6650196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat.
    Rattan AK; Koo KL; Tejwani GA; Bhargava HN
    Brain Res; 1992 Jul; 584(1-2):207-12. PubMed ID: 1355391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intrathecal morphine, clonidine, and midazolam on the somato-sympathoadrenal reflex response in halothane-anesthetized cats.
    Gaumann DM; Yaksh TL; Tyce GM
    Anesthesiology; 1990 Sep; 73(3):425-32. PubMed ID: 2393126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of morphine, pethidine, diamorphine and nalorphine on the cat and rabbit.
    Grundy HF
    Br J Pharmacol; 1971 Jun; 42(2):159-78. PubMed ID: 4103858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical correlates of morphine withdrawal. 1. Characterization in the adrenal medulla and locus ceruleus.
    DiStefano PS; Brown OM
    J Pharmacol Exp Ther; 1985 May; 233(2):333-8. PubMed ID: 2860239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral administration of an angiotensin II AT(1) receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation Stress.
    Armando I; Carranza A; Nishimura Y; Hoe KL; Barontini M; Terrón JA; Falcón-Neri A; Ito T; Juorio AV; Saavedra JM
    Endocrinology; 2001 Sep; 142(9):3880-9. PubMed ID: 11517166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal.
    Skelton KH; Oren D; Gutman DA; Easterling K; Holtzman SG; Nemeroff CB; Owens MJ
    Eur J Pharmacol; 2007 Sep; 571(1):17-24. PubMed ID: 17610870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of morphine on hypothalamic catecholamine and serotonin level in relation to the stress-induced pituitary-adrenocortical activation in the rat.
    Debreceni L; Hartmann G; Debreceni B
    Exp Clin Endocrinol; 1994; 102(4):307-12. PubMed ID: 7813602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects.
    Rittmaster RS; Cutler GB; Sobel DO; Goldstein DS; Koppelman MC; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1985 May; 60(5):891-5. PubMed ID: 2984235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 36. Morphine withdrawal-induced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones.
    Laorden ML; Núñez C; Almela P; Milanés MV
    J Neurochem; 2002 Oct; 83(1):132-40. PubMed ID: 12358736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response.
    Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
    J Pharmacol Exp Ther; 1998 May; 285(2):700-6. PubMed ID: 9580616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxytocin in corticosterone-induced chronic stress model: Focus on adrenal gland function.
    Stanić D; Plećaš-Solarović B; Mirković D; Jovanović P; Dronjak S; Marković B; Đorđević T; Ignjatović S; Pešić V
    Psychoneuroendocrinology; 2017 Jun; 80():137-146. PubMed ID: 28343139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VI. Catecholamine metabolism in the brain and adrenal medulla during addiction to morphine and in the early abstinence period.
    Maynert EW
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():89-95. PubMed ID: 5749391
    [No Abstract]   [Full Text] [Related]  

  • 40. Changes in hypothalamic paraventricular nucleus catecholaminergic activity after acute and chronic morphine administration.
    Fuertes G; Milanés MV; Rodríguez-Gago M; Marín MT; Laorden ML
    Eur J Pharmacol; 2000 Jan; 388(1):49-56. PubMed ID: 10657546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.